• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Heliyon . Standardized reporting systems of chest computed tomography in a population with low coronavirus disease 2019 prevalence: A retrospective

tetano

Editor, Senior Moderator
Heliyon


. 2021 Aug;7(8):e07743.
doi: 10.1016/j.heliyon.2021.e07743. Epub 2021 Aug 10.
Standardized reporting systems of chest computed tomography in a population with low coronavirus disease 2019 prevalence: A retrospective comparative study


Ryo Kurokawa[SUP] 1 [/SUP], Shohei Inui[SUP] 1 [/SUP], Wataru Gonoi[SUP] 1 [/SUP], Yudai Nakai[SUP] 1 [/SUP], Masanori Ishida[SUP] 1 [/SUP], Yusuke Watanabe[SUP] 1 [/SUP], Takatoshi Kubo[SUP] 1 [/SUP], Yosuke Amano[SUP] 2 [/SUP], Koh Okamoto[SUP] 3 [/SUP], Hidenori Kage[SUP] 2 [/SUP], Sohei Harada[SUP] 4 [/SUP], Goh Tanaka[SUP] 2 [/SUP], Takuya Kawahara[SUP] 5 [/SUP], Takahide Nagase[SUP] 2 [/SUP], Kyoji Moriya[SUP] 3 [/SUP], Osamu Abe[SUP] 1 [/SUP]



Affiliations

Abstract

Purpose: To compare the diagnostic performance and interobserver agreement of three reporting systems for computed tomography findings in coronavirus disease 2019 (COVID-19), namely the COVID-19 Reporting and Data System (CO-RADS), COVID-19 Imaging Reporting and Data System (COVID-RADS), and Radiological Society of North America (RSNA) expert consensus statement, in a low COVID-19 prevalence area.
Method: This institutional review board approval single-institutional retrospective study included 154 hospitalized patients between April 1 and May 21, 2020; 26 (16.9 %; 63.2 ± 14.1 years, 21 men) and 128 (65.7 ± 16.4 years, 87 men) patients were diagnosed with and without COVID-19 according to reverse transcription-polymerase chain reaction results, respectively. Written informed consent was waived due to the retrospective nature of the study. Six radiologists independently classified chest computed tomography images according to each reporting system. The area under receiver operating characteristic curves, sensitivity, specificity, positive predictive value, negative predictive value, accuracy, and interobserver agreements were calculated and compared across the systems using paired t-test and kappa analysis.
Results: Mean area under receiver operating characteristic curves were as follows: CO-RADS, 0.89 (95 % confidence interval [CI], 0.87-0.90); COVID-RADS, 0.78 (0.75-0.80); and RSNA expert consensus statement, 0.88 (0.86-0.90). Average kappa values across observers were 0.52 (95 % CI: 0.45-0.60), 0.51 (0.41-0.61), and 0.57 (0.49-0.64) for CO-RADS, COVID-RADS, and RSNA expert consensus statement, respectively. Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were the highest at 0.71, 0.53, 0.72, 0.96, and 0.56 in the CO-RADS; 0.56, 0.31, 0.54, 0.95, and 0.35 in the COVID-RADS; 0.83, 0.49, 0.61, 0.96, and 0.55 in the RSNA expert consensus statement, respectively.
Conclusions: The CO-RADS exhibited the highest specificity, positive predictive value, which are especially important in a low-prevalence population, while maintaining high accuracy and negative predictive value, demonstrating the best performance in a low-prevalence population.

Keywords: COVID-19; Chest computed tomography; Diagnostic performance; Interobserver agreement.
 
Back
Top Bottom